Sat, Nov 29, 2014, 4:59 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

XOMA Corporation Message Board

  • mdwhittier mdwhittier Nov 3, 2013 12:58 PM Flag

    Biotech's Malaise and XOMA

    The whole biotech sector is in "sell the news" and "risk off" mode, with too much hot money chasing the sector over the past year. Now, the short sellers are capitalizing on the downtrend. What's new about that?

    For some reason, an option player is still betting big bucks for the stock to be over $5 a share before long. Gevo is a solid drug with multiple indications, but nothing blockbuster at this stage. If EOA data look impressive at 6 months (leveling off of placebo and further positive trends for tx arm), alongside other indications which are forthcoming, we will see at least $8-10 in late 2014. I'm betting that Gevo pays the bills until X-Met lights the rocket. GLTA

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
5.69-0.01(-0.18%)Nov 28 1:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
BP p.l.c.
NYSEFri, Nov 28, 2014 1:02 PM EST